Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias
- PMID: 38928276
- PMCID: PMC11203996
- DOI: 10.3390/ijms25126570
Advancements in Biomarkers and Molecular Targets in Hematological Neoplasias
Abstract
Hematological neoplasias are among the most common cancers worldwide, and the number of new cases has been on the rise since 1990, reaching 1 [...].
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Bailey M.H., Tokheim C., Porta-Pardo E., Sengupta S., Bertrand D., Weerasinghe A., Colaprico A., Wendl M.C., Kim J., Reardon B., et al. Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.Cell.2018.02.060)) Cell. 2018;174:1034–1035. doi: 10.1016/j.cell.2018.07.034. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
